Form 13-F position report

KALA PHARMACEUTICALS INC. COM

Reported by Parallel Advisors LLC

KALA CUSIP 483119103 Manager CIK 0001690010

Reported 0 shares, down 1 (100.0%) from the prior quarter.

Reduced
% of reported 13F value 0 This manager · Q2 2026
Shares 0 Quarter-end amount reported
Reported value $0 Fair value at quarter end
Consecutive quarters held 22 Through Q2 2026

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2021-12-31 0
2022-03-31 0
2022-06-30 0
2022-09-30 0
2022-12-31 38
2023-03-31 15
2023-06-30 15
2023-09-30 9
2023-12-31 7
2024-03-31 8
2024-06-30 7
2024-09-30 6
2024-12-31 7
2025-03-31 6
2025-06-30 5
2025-09-30 2
2025-12-31 0
2026-03-31 0
2026-06-30 0

Quarterly position history

How this manager's reported quarter-end position changed over time.

19 quarters
Quarterly reported position history for KALA PHARMACEUTICALS INC. COM held by Parallel Advisors LLC.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q2 2026 Reduced 0 -1 (-100.0%) 0 $0 2026-08-05
Q1 2026 New 1 +1 (0.0%) 0 $0 2026-05-07
Q4 2025 Reduced 0 -1 (-100.0%) 0 $0 2026-02-11
Q3 2025 Unchanged 1 0 (0.0%) < 0.01% $2 2025-11-13
Q2 2025 Unchanged 1 0 (0.0%) < 0.01% $5 2025-07-08
Q1 2025 Unchanged 1 0 (0.0%) < 0.01% $6 2025-04-08
Q4 2024 Unchanged 1 0 (0.0%) < 0.01% $7 2025-02-10
Q3 2024 Unchanged 1 0 (0.0%) < 0.01% $6 2024-11-13
Q2 2024 Unchanged 1 0 (0.0%) < 0.01% $7 2024-08-08
Q1 2024 Unchanged 1 0 (0.0%) < 0.01% $8 2024-05-06
Q4 2023 Unchanged 1 0 (0.0%) < 0.01% $7 2024-02-12
Q3 2023 Unchanged 1 0 (0.0%) < 0.01% $9 2023-11-14
Q2 2023 Unchanged 1 0 (0.0%) < 0.01% $15 2023-08-04
Q1 2023 Unchanged 1 0 (0.0%) < 0.01% $15 2023-04-25
Q4 2022 Reduced 1 -49 (-98.0%) < 0.01% $38 2023-02-06
Q3 2022 Unchanged 50 0 (0.0%) 0 $0 2022-11-10
Q2 2022 Unchanged 50 0 (0.0%) 0 $0 2022-08-01
Q1 2022 Unchanged 50 0 (0.0%) 0 $0 2022-04-28
Q4 2021 Unchanged 50 0 (0.0%) 0 $0 2022-01-20
Five years are shown. A free account unlocks the complete reported history. Unlock full history

Who else reported the position

3 managers reported KALA PHARMACEUTICALS INC. COM for Q2 2026.

Managers reporting KALA PHARMACEUTICALS INC. COM in Q2 2026.
Manager Activity Shares Change % of reported 13F Reported value Tenure
HARBOUR INVESTMENTS INC Unchanged 3 0 < 0.01% $5 2 qtrs
Parallel Advisors LLC This report Reduced 0 -1 0 $0 22 qtrs
Cheviot Value Management LLC Reduced 0 -153 0 $0 6 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
June 30, 2026
Filed
August 05, 2026
Filing type
13F-HR
Position type
Stock

Voting authority reported

No voting-authority amounts were reported for this position. Voting authority is not required for reported call options.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.